Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.78 USD | -4.14% | -32.48% | -43.14% |
02:12pm | Piper Sandler Cuts Akoya Biosciences Price Target to $6 From $8, Maintains Overweight Rating | MT |
05-14 | Top Midday Decliners | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-43.14% | 143M | |
+13.21% | 227B | |
+13.95% | 192B | |
+17.71% | 136B | |
+28.52% | 108B | |
+1.67% | 64.07B | |
+17.62% | 52.1B | |
+7.04% | 51.87B | |
+10.74% | 44.33B | |
+5.41% | 36.75B |
- Stock Market
- Equities
- AKYA Stock
- News Akoya Biosciences, Inc.
- Transcript : Akoya Biosciences, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-10-2024 03